HBV-IN-47 (compound 4a) functions as a capsid assembly modulator with activity against the hepatitis B virus (HBV). It exhibits potent anti-HBV activity in HepAD38 cells and has low toxicity (EC50=0.24 µM). This compound is applicable for research into chronic hepatitis B (CHB).
Target:
HBV
* VAT and and shipping costs not included. Errors and price changes excepted